The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 27, 2016

Filed:

Jul. 29, 2015
Applicant:

Neothetics Inc., San Diego, CA (US);

Inventors:

John Daniel Dobak, La Jolla, CA (US);

Kenneth Walter Locke, Carlsbad, CA (US);

Assignee:

NEOTHETICS, INC., San Diego, CA (US);

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A01N 43/00 (2006.01); A61K 31/33 (2006.01); A61K 9/00 (2006.01); A61K 31/568 (2006.01); A61K 31/137 (2006.01); A61K 31/167 (2006.01); A61K 31/56 (2006.01); A61K 31/573 (2006.01); A61K 31/58 (2006.01);
U.S. Cl.
CPC ...
A61K 9/0019 (2013.01); A61K 31/137 (2013.01); A61K 31/167 (2013.01); A61K 31/56 (2013.01); A61K 31/568 (2013.01); A61K 31/573 (2013.01); A61K 31/58 (2013.01);
Abstract

Provided herein are pharmaceutical formulations, methods, and systems for treating regional fat deposits and fat-related conditions and indications. Methods comprise administering a pharmaceutical formulation comprising a long-acting beta-2 adrenergic receptor agonist, for example, salmeterol, suitable for subcutaneous administration. Formulations comprise a pharmaceutical formulation that is suitable for subcutaneous injection comprising: (a) a lipophilic long-acting selective beta-2 adrenergic receptor agonist, or a salt thereof; and (b) at least one subcutaneously acceptable inactive ingredient.


Find Patent Forward Citations

Loading…